Page last updated: 2024-11-08

pentylenetetrazole and Amyotonia Congenita

pentylenetetrazole has been researched along with Amyotonia Congenita in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research Excerpts

ExcerptRelevanceReference
"For the former, the MES test, clonic seizures induced by pentylenetetrazol, 90 mg/kg, s."1.26Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse. ( Blake, GJ; Gilbert, MB; Raines, A; Richardson, B, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raines, A1
Blake, GJ1
Richardson, B1
Gilbert, MB1

Other Studies

1 other study available for pentylenetetrazole and Amyotonia Congenita

ArticleYear
Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse.
    Epilepsia, 1979, Volume: 20, Issue:2

    Topics: Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Male; Mice; Neuromuscular Disease

1979